R&D
Mosquitoes, malaria, and UK R&D viral disease vaccine invest...
The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.
Market Access
Pharma’s most expensive question is the last one asked
Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.
R&D
Scientists and algorithms: Finding the right balance in mode...
The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
Sales & Marketing
Sponsored
Local voices, global reach
Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.
Sales & Marketing
Beyond omnichannel: Why pharma commercialisation must shift ...
We need to step away from the passive, broad concept of omnichannel and adopt a far more active, disciplined framework: omnideployment.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
